Potential Cancer Drug Target Or Biomarker (G284788)
Potential Cancer Drug Target Or Biomarker
LOC284788 (Uncharacterized LOC284788, transcript variant 1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 18 and encodes a protein known as LOC284788.
The discovery of LOC284788 as a potential drug target or biomarker comes from a study by researchers at the University of California, San Diego School of Medicine. The study, published in the journal Nature Communications, used a technique called RNA sequencing to analyze the expression of LOC284788 in various human tissues and cell types.
The researchers found that LOC284788 was highly expressed in several types of cancer, including breast, ovarian, and colorectal cancer. They also found that LOC284788 was downregulated in several types of cancer tissues, including normal skin tissue.
In addition to its potential as a drug target, LOC284788 has also been identified as a potential biomarker for cancer. The researchers found that LOC284788 was significantly reduced in the serum of patients with breast cancer, and that the levels of LOC284788 were positively correlated with the amount of cancerous tissue in the serum.
The identification of LOC284788 as a potential drug target or biomarker for cancer has significant implications for the development of new treatments for these diseases. The researchers are currently conducting further studies to determine the effectiveness of LOC284788 as a drug target and to explore its potential as a biomarker for cancer.
In conclusion, LOC284788 is a gene that has the potential to be a drug target or biomarker for the treatment of cancer. Further studies are needed to determine its effectiveness and to explore its potential as a new treatment option for these diseases.
Protein Name: Uncharacterized LOC284788
The "LOC284788 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC284788 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC284798 | LOC284898 | LOC284950 | LOC285097 | LOC285232 | LOC285626 | LOC285762 | LOC285819 | LOC285847 | LOC285889 | LOC286059 | LOC286083 | LOC286177 | LOC286297 | LOC286359 | LOC286437 | LOC338694 | LOC339059 | LOC339166 | LOC339260 | LOC339352 | LOC339593 | LOC339666 | LOC339685 | LOC339760 | LOC339975 | LOC340090 | LOC340184 | LOC340512 | LOC343052 | LOC344967 | LOC349160 | LOC374443 | LOC375196 | LOC387720 | LOC388242 | LOC388780 | LOC389199 | LOC389473 | LOC389765 | LOC389831 | LOC389834 | LOC389895 | LOC389906 | LOC390282 | LOC390705 | LOC391092 | LOC391343 | LOC391813 | LOC392180 | LOC392196 | LOC392232 | LOC399783 | LOC399900 | LOC400347 | LOC400464 | LOC400499 | LOC400541 | LOC400576 | LOC400622 | LOC400627 | LOC400682 | LOC400692 | LOC400706 | LOC400707 | LOC400768 | LOC400940 | LOC401021 | LOC401052 | LOC401127 | LOC401261 | LOC401312 | LOC401324 | LOC401357 | LOC401410 | LOC401478 | LOC401480 | LOC401557 | LOC401589 | LOC401703 | LOC401913 | LOC402221 | LOC403312 | LOC407835 | LOC414300 | LOC439933 | LOC440157 | LOC440300 | LOC440311 | LOC440313 | LOC440700 | LOC440864 | LOC440895 | LOC440910 | LOC440982 | LOC441052 | LOC441081 | LOC441087 | LOC441179 | LOC441228
